ASLAN Pharma (NASDAQ:ASLN) just reported results for the first quarter of 2024. ASLAN Pharma reported earnings per share of -53 cents. This was above the analyst estimate for EPS of -61 cents. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results